GLIOBLASTOMA MULTIFORME
Clinical trials for GLIOBLASTOMA MULTIFORME explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain cancer vaccine targets survivin protein to boost immune attack
Disease control Not yet recruitingThis phase II trial tests whether a personalized dendritic cell vaccine targeting the Survivin protein can improve survival in people with newly diagnosed glioblastoma, an aggressive brain cancer. Participants receive the vaccine alongside standard chemotherapy after surgery. The…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE2 • Sponsor: Beijing Tricision Biotherapeutics Inc • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New pill shows promise in brain cancer fight
Disease control Not yet recruitingThis study tests whether adding NG101m capsules to standard chemoradiation helps people with newly diagnosed glioblastoma live longer. About 52 adults will receive NG101m alongside usual care. The goal is to see if the combination is safe and improves 2-year survival.
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1, PHASE2 • Sponsor: NeuGATE Theranostics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New study aims to decode glioblastoma through brain scans and blood markers
Knowledge-focused Not yet recruitingThis study will include 30 people newly diagnosed with glioblastoma, the most common and aggressive brain tumor. Researchers will use a special MRI technique called magnetic resonance spectroscopy (MRS) to measure chemicals in the tumor, and also test blood for certain markers. T…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC